Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 4 of 29
Effects of RAS on Gait in PD Patients With DBS
NCT05763732
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery
NCT05935735
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NCT06128928
Dinner Time for Obesity and Prediabetes
NCT05745441
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
NCT05994014
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
NCT05608421
Producing Increasingly Complex Themes Using Right-hemisphere Engagement (PICTURE) Implemented With Telemedicine
NCT05845047
Trial to Determine Effective Aspirin Dose in COPD
NCT05265299
Scrambler Therapy for Post-Stroke Pain
NCT05563038
Estrogen Supplementation and Bone Health in Women With CF
NCT05704036
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
NCT05619705
Effects of Recorded Music on Clinical and EEG Seizure Activity
NCT05289934
Cannabidiol (CBD) in Adults With ASD
NCT05015439
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
NCT05653232
Vestibular Implantation in Older Adults
NCT05676944
Alcohol Research in HIV: Relapse Prevention
NCT05163301
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
NCT05672615
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
NCT05795634
Uterus Transplantation to Treat Infertility
NCT05646992
Deep Brain Stimulation in Treatment Resistant Schizophrenia
NCT02361554
Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
NCT05674786
Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
NCT05241990
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
NCT05282550
Study of Healthy Cohort for Early Detection of Cancer
NCT05193305
Gender Related Coping and Survivorship for Genitourinary Cancers
NCT05649306
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
NCT05252754
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
NCT05579743
Predicting Outcomes in Hypoglossal Nerve Stimulation Therapy With Stimulated Upper Airway Mechanics
NCT05429983
Effects of Psilocybin in Obsessive Compulsive Disorder
NCT05546658
Imaging the Pathogenesis of Cerebral Small Vessel Disease
NCT05703386
Oral Cannabidiol for Tobacco Cessation
NCT05445804
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
NCT03887481
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
NCT05020535
Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record
NCT05503771
TDCS to Improve Post-Stroke Cognitive Impairment
NCT05195398
Vestibular Therapy in Alzheimer's Disease
NCT03799991
Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants
NCT05324982
StableEyes With Active Neurofeedback
NCT05622344
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
NCT04989790
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794
Music Therapy for Patients With Alzheimer's Disease
NCT05151562
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
NCT05463289
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
NCT05556395
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
NCT05145764
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NCT04162938
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
NCT05301608
Developing a Clinical Outcome Assessment for Opioid Craving
NCT05109429
OMEGA - Dietary Intervention - COPD Trial
NCT05297279
Economic Incentives and vDOT for Latent Tuberculosis Infection
NCT05022862
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.